Steven Schoenfeld Email

VP Clinical Development . Galectin Therapeutics

Current Roles

Employees:
41
Revenue:
$3.5M
About
Pro-Pharmaceuticals is a drug development company commercializing a new generation of anti-cancer treatments using carbohydrate molecules to significantly upgrade the safety and efficacy of standard cancer agents. Trading under the symbol PROH.OB, the company is headquartered in Newton, Mass., and was founded in 2000.
Galectin Therapeutics Address
4960 Peachtree Industrial Boulevard
Norcross, GA
United States
Galectin Therapeutics Email

Past Companies

FreelanceSemi Retired
Galectin TherapeuticsVice President Clinical Development
Bristol-Myers SquibbCTP

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.